Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme

Abstract

In skeletal muscle, acetylcholinesterase (AChE) exists in homomeric globular forms of type T catalytic subunits (ACHET) and heteromeric asymmetric forms composed of 1, 2, or 3 tetrameric ACHETattached to a collagenic tail (ColQ). Asymmetric AChE is concentrated at the endplate (EP), where its collagenic tail anchors it into the basal lamina. TheACHETgene has been cloned in humans;COLQcDNA has been cloned inTorpedoand rodents but not in humans. In a disabling congenital myasthenic syndrome, EP AChE deficiency (EAD), the normal asymmetric species of AChE are absent from muscle. EAD could stem from a defect that prevents binding of ColQ to ACHETor the insertion of ColQ into the basal lamina. In six EAD patients, we found no mutations inACHET. We therefore cloned humanCOLQcDNA, determined the genomic structure and chromosomal localization ofCOLQ, and then searched for mutations in this gene. We identified six recessive truncation mutations ofCOLQin six patients. Coexpression of eachCOLQmutant with wild-typeACHETin SV40-transformed monkey kidney fibroblast (COS) cells reveals that a mutation proximal to the ColQ attachment domain for ACHETprevents association of ColQ with ACHET; mutations distal to the attachment domain generate a mutant ≈10.5S species of AChE composed of one ACHETtetramer and a truncated ColQ strand. The ≈10.5S species lack part of the collagen domain and the entire C-terminal domain of ColQ, or they lack only the C-terminal domain, which is required for formation of the triple collagen helix, and this likely prevents their insertion into the basal lamina.